Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on May 02, 2019 11:47am
47 Views
Post# 29701110

RE:RE:RE:RE:RE:RE:Think Equity Conference talk - positive? same story?

RE:RE:RE:RE:RE:RE:Think Equity Conference talk - positive? same story?Not sure how PYR is surprising, they actually gave information about the expected contract.  I'm sure if CZO actually gets a contract of $50-$70 million, the share price might go up 10%-15% like PYR.

All CZO investors know is that 2017 will be a transformational year and the company will have a significant PGX deal by the end of 2018.  Still waiting on something to actually happen (and no, mentioning a possible "major event" doesn't count).

Also trying to value companies by a multiple of what they spend on R&D may not be the best investment strategy...

digitel wrote: "Expecting Q1 results shortly in about two weeks or so as last year they were released on May 17.
So if the revenues start improving we could finally start to see a turnaround in the share price."

The quarter-to-quarter profitability of the base business is a distraction in the context of the potential for deals and given the market cap. The financials should be looked at on a rolling 12 month basis. At a $30 million market cap the stock is trading at just 11.5 times what they spent on R&D last year. The stock is ridiculously cheap and is already punished for its lumpiness. 

PYR just reported a terrible quarter but the stock surprised many and went up because of an expected major imminent deal.


Bullboard Posts